Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > From Linkedin

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jul 22, 2024 8:06pm

72 Views

Post# 36143550

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:From Linkedin

All the Dems have to do is lie and lie some more, and you people fall for every lie they tell you, just like the lies about Biden's alziemers affliction, while the Dems told the world that he was "as sharp as a tack".... and he was "the smartest guy in the room", and " he had more energy than most of his staff"....all blatant lies, and you swallowed every one of them

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks